Medical School · Year 2 · Pathology · includes a quiz and discussion video

Lecture 01: Cell Injury and Adaptation

Unit 2.11: Pathology

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the mechanisms and causes of cell injury
2. Explain the difference between reversible and irreversible cell injury
3. Describe the morphologic changes in cell injury and death
4. Explain the mechanisms of necrosis and apoptosis
5. Describe cellular adaptations to stress
6. Explain intracellular accumulations and calcification

Lecture Outline

I. Overview of Cell Injury

Cell injury represents a fundamental concept in pathology, occurring when cells are exposed to stressors that exceed their adaptive capacity. The causes of cell injury span multiple categories including hypoxia from conditions such as ischemia, hypoxemia, and anemia, which deprive cells of oxygen necessary for aerobic metabolism. Physical agents including mechanical trauma, extremes of temperature, and ionizing radiation can directly damage cellular structures and compromise cell viability. Chemical agents ranging from therapeutic drugs to environmental toxins and poisons exert their effects through various biochemical mechanisms that disrupt normal cellular function.

Infectious agents including bacteria, viruses, fungi, and parasites cause cell injury through direct cytopathic effects or by triggering inflammatory responses. Immunologic reactions encompass hypersensitivity responses and autoimmune conditions where the immune system inappropriately targets host tissues. Genetic defects represent inherited abnormalities that predispose cells to injury or impair their ability to respond to stress. Nutritional imbalances, whether deficiencies or excesses of essential nutrients, compromise cellular metabolism and structural integrity.

The principal targets of cell injury include mitochondria, where damage leads to ATP depletion and energy failure critical for maintaining cellular homeostasis. The cell membrane serves as another vital target, with injury causing ion imbalances and loss of cellular contents into the extracellular space. Disruption of protein synthesis impairs the cell's ability to maintain normal function and respond to stress. DNA damage can result in mutations, activation of cell death pathways, or malignant transformation, while cytoskeletal injury leads to structural failure and loss of cell shape.

The response to injury depends on multiple determinants including the nature, duration, and severity of the injurious stimulus. Different cell types demonstrate varying vulnerabilities, with neurons being highly sensitive to hypoxia while hepatocytes possess considerable regenerative capacity. The metabolic state of the cell, including whether it is in a fed or fasted condition, influences its ability to withstand stress. Cellular responses range from successful adaptation through altered steady states, to reversible injury with potential recovery, to irreversible injury culminating in cell death, or chronic injury manifesting as fibrosis and atrophy.

<image>Panel A: Schematic diagram showing the major categories of cell injury causes arranged in a circular pattern around a central cell, including hypoxia, physical agents, chemical toxins, infectious organisms, and immunologic factors. Panel B: Detailed cross-section of a cell highlighting the five major targets of cellular injury - mitochondria, cell membrane, ribosomes for protein synthesis, nuclear DNA, and cytoskeleton - each labeled with their associated consequences. Panel C: Flowchart demonstrating the progression from normal cell through adaptation, reversible injury, and irreversible injury leading to cell death. Panel D: Comparison diagram showing cells with different metabolic states and their vulnerability to identical injurious stimuli.</image>

II. Mechanisms of Cell Injury

ATP depletion represents one of the most critical mechanisms of cell injury, as adenosine triphosphate is essential for virtually all energy-dependent cellular processes. When ATP levels fall, the sodium-potassium ATPase pump fails, leading to sodium accumulation inside the cell and potassium efflux, resulting in cell swelling from osmotic water influx. The shift to anaerobic glycolysis produces lactic acid, causing intracellular acidosis that denatures proteins and impairs enzyme function. Calcium pump failure allows cytosolic calcium concentrations to rise dramatically, triggering a cascade of destructive enzymatic processes.

Mitochondrial damage occupies a central position in the pathophysiology of cell injury due to the organelle's role in ATP production and regulation of cell death pathways. Decreased oxidative phosphorylation reduces ATP generation, creating an energy deficit that compromises all cellular functions. Damaged mitochondria generate increased reactive oxygen species that cause oxidative damage to lipids, proteins, and DNA. Opening of the mitochondrial permeability transition pore releases cytochrome c into the cytoplasm, initiating the intrinsic apoptotic pathway and committing the cell to death.

Calcium influx into the cytoplasm activates multiple destructive enzymes including phospholipases that degrade membrane phospholipids, proteases that destroy cytoskeletal and membrane proteins, and endonucleases that fragment DNA. Elevated intracellular calcium promotes mitochondrial permeability transition, further amplifying cellular damage. Calcium-activated enzymes generate a feed-forward loop of injury, with membrane damage allowing more calcium entry. The accumulation of calcium in mitochondria impairs their function and contributes to the irreversibility of severe cell injury.

Oxidative stress arises from an imbalance between the production of reactive oxygen species and the cell's antioxidant defenses. Normal mitochondrial metabolism generates small amounts of ROS as byproducts, but this production increases dramatically during ischemia-reperfusion injury. Inflammatory cells generate ROS through the respiratory burst as part of their microbicidal activity, while drugs and chemicals may be metabolized to free radical intermediates. Ionizing radiation directly generates ROS that cause DNA strand breaks and other molecular damage, contributing to both acute cell injury and long-term carcinogenic effects.

<image>Panel A: Molecular diagram showing ATP depletion cascades including sodium-potassium pump failure, cellular swelling, and ribosome detachment from endoplasmic reticulum. Panel B: Illustration of a damaged mitochondrion with electron transport chain dysfunction, ROS generation, and mitochondrial permeability transition pore opening with cytochrome c release. Panel C: Diagram depicting calcium influx through damaged membrane channels and its effects on activating phospholipases, proteases, and endonucleases throughout the cell. Panel D: Oxidative stress pathway showing sources of reactive oxygen species from mitochondria, inflammatory cells, and drug metabolism converging on cellular targets.</image>

III. Reactive Oxygen Species

Reactive oxygen species encompass a family of oxygen-derived molecules with unpaired electrons that make them highly reactive with biological molecules. Superoxide anion is generated primarily in mitochondria and by NADPH oxidase in phagocytes, serving as the precursor for other ROS. Hydrogen peroxide, formed by superoxide dismutase activity, can cross membranes and participate in generating the highly reactive hydroxyl radical. The hydroxyl radical represents the most damaging ROS, capable of reacting with virtually any biological molecule at diffusion-limited rates.

The targets of ROS-mediated damage include membrane lipids, where peroxidation of polyunsaturated fatty acids disrupts membrane structure and generates toxic aldehyde byproducts. Protein damage from oxidation leads to cross-linking, fragmentation, and loss of enzymatic function, impairing cellular metabolism and signaling. DNA sustains oxidative damage including base modifications and strand breaks that can cause mutations or trigger cell death pathways. Carbohydrate modifications alter cell surface glycoproteins and proteoglycans, potentially affecting cell-cell interactions and signaling.

Cells possess elaborate antioxidant defense systems to neutralize reactive oxygen species before they cause damage. Superoxide dismutase converts superoxide anion to hydrogen peroxide, which is then detoxified by catalase in peroxisomes or by glutathione peroxidase in the cytoplasm and mitochondria. The glutathione system requires NADPH for regeneration of reduced glutathione, linking antioxidant defense to cellular metabolic status. Vitamin E serves as a lipid-soluble antioxidant that protects membrane lipids, while vitamin C provides cytosolic antioxidant capacity and regenerates oxidized vitamin E.

Pathologic states involving oxidative stress include ischemia-reperfusion injury, where reoxygenation of ischemic tissue triggers a burst of ROS generation that paradoxically causes additional damage. Chronic inflammation involves sustained ROS production by activated phagocytes, contributing to tissue destruction in autoimmune diseases. Accumulation of oxidative damage over time is implicated in the aging process and age-related degenerative conditions. Oxidative DNA damage contributes to mutagenesis and carcinogenesis, with ROS playing roles in tumor initiation and promotion.

<image>Panel A: Chemical structures of the four major reactive oxygen species - superoxide anion, hydrogen peroxide, hydroxyl radical, and peroxynitrite - with their respective molecular formulas and reactivity indicators. Panel B: Diagram showing lipid peroxidation chain reaction in a cell membrane, with propagation of damage through polyunsaturated fatty acids. Panel C: Illustration of the major antioxidant defense systems including superoxide dismutase, catalase, and glutathione peroxidase pathways with their cellular locations. Panel D: Timeline showing ROS generation during ischemia-reperfusion injury with the paradoxical increase in oxidative damage upon reoxygenation.</image>

IV. Reversible vs Irreversible Injury

Reversible cell injury is characterized by functional and morphologic changes that can return to normal if the injurious stimulus is removed before critical damage occurs. Cell swelling represents the earliest morphologic manifestation, resulting from failure of energy-dependent ion pumps and subsequent osmotic water influx. Fatty change, or steatosis, develops when lipid metabolism is disrupted, causing triglyceride accumulation within the cytoplasm. Plasma membrane blebbing reflects cytoskeletal damage and appears as irregular outpouchings of the cell surface.

Additional features of reversible injury include mitochondrial swelling and endoplasmic reticulum dilation with detachment of ribosomes from the rough ER surface. Chromatin undergoes margination and clumping at the nuclear periphery, reflecting early DNA damage and transcriptional changes. The cytoplasm may appear more eosinophilic on histologic examination due to loss of cytoplasmic RNA and protein denaturation. These changes indicate cellular stress but maintain the possibility of recovery with removal of the injurious stimulus and restoration of ATP synthesis.

The point of no return from reversible to irreversible injury is marked by several critical events that commit the cell to death. Severe membrane damage causes loss of selective permeability, allowing uncontrolled ion flux and leakage of intracellular enzymes into the bloodstream where they serve as biomarkers of tissue damage. Profound mitochondrial dysfunction, particularly opening of the mitochondrial permeability transition pore, prevents restoration of ATP synthesis. Massive calcium overload activates degradative enzymes that cause irreversible damage to cellular structures.

Irreversible injury manifests with distinctive morphologic features including severe membrane damage with ion pump failure and continuing cellular swelling. Mitochondria show dense amorphous bodies reflecting calcium-phosphate precipitates within the matrix. Lysosomal rupture releases hydrolytic enzymes that digest cellular components in a process of autolysis. Nuclear changes characteristic of cell death include pyknosis (nuclear shrinkage and hyperchromasia), karyorrhexis (nuclear fragmentation), and karyolysis (dissolution of the nucleus), representing the definitive morphologic markers of irreversible injury.

<image>Panel A: Electron micrograph illustration of reversible injury showing cell swelling, mitochondrial swelling, ER dilation with ribosome detachment, and chromatin margination. Panel B: Diagram depicting the molecular point of no return with membrane breakdown, MPT pore opening, and calcium overload. Panel C: Comparison of ultrastructural features in reversible versus irreversible injury shown side by side. Panel D: Nuclear changes in irreversible injury showing the progression from pyknosis through karyorrhexis to karyolysis with corresponding histologic appearances.</image>

V. Necrosis

Necrosis represents the morphologic changes that occur after cell death in living tissue, resulting from the progressive degradation of cellular components by enzymes. Unlike apoptosis, necrosis is considered a pathologic form of cell death that occurs in response to severe, irreversible injury beyond the cell's capacity for repair. A defining characteristic of necrosis is the associated inflammatory response, as cellular contents released from dead cells stimulate acute inflammation. The enzymes responsible for cellular degradation derive from both lysosomes of the dying cells themselves and from infiltrating inflammatory cells, particularly neutrophils.

The morphologic features of necrosis include cell swelling due to loss of membrane integrity and inability to maintain osmotic gradients. The cytoplasm becomes increasingly eosinophilic as proteins denature and bind more avidly to eosin dye in histologic preparations. Nuclear changes progress through pyknosis, karyorrhexis, and karyolysis as chromatin is degraded by endonucleases. Membrane disruption is evident as discontinuities in the plasma membrane, distinguishing necrosis from apoptosis where membrane integrity is maintained until late stages.

Different patterns of necrosis reflect variations in the cause of cell death and the tissue involved. Coagulative necrosis preserves the basic tissue architecture despite cell death, creating a firm texture, and typically occurs in solid organs such as the heart and kidney following ischemic infarction. Liquefactive necrosis involves complete enzymatic digestion of dead tissue, resulting in a soft, liquid mass, and characterizes brain infarcts and bacterial abscesses where neutrophil enzymes predominate. Caseous necrosis exhibits a distinctive cheesy, amorphous appearance and is pathognomonic of tuberculosis and certain fungal infections.

Fat necrosis occurs when lipases act on adipose tissue, releasing fatty acids that complex with calcium to form chalky white areas of saponification, classically seen in acute pancreatitis. Gangrenous necrosis represents coagulative necrosis modified by superimposed bacterial infection and is seen in ischemic extremities. Fibrinoid necrosis appears as bright pink, homogeneous deposits of immunoglobulin and fibrin in vessel walls, occurring in malignant hypertension and immune-mediated vasculitis. Recognition of these patterns provides important diagnostic clues regarding the underlying cause of tissue injury.

<image>Panel A: Histologic comparison of coagulative necrosis showing preserved tissue architecture with ghost outlines of cells in an ischemic kidney. Panel B: Gross and microscopic appearance of liquefactive necrosis in brain tissue and a bacterial abscess with neutrophilic infiltrate. Panel C: Caseous necrosis within a tuberculous granuloma showing the amorphous eosinophilic center surrounded by epithelioid cells and giant cells. Panel D: Fat necrosis in pancreatic tissue with chalky white calcium soap deposits and surrounding acute inflammation.</image>

VI. Apoptosis

Apoptosis is the pathway of programmed cell death characterized by energy-dependent activation of specific enzymatic cascades that lead to orderly cellular dismantling. In contrast to necrosis, apoptosis serves essential physiologic functions including elimination of cells during embryonic development, maintenance of appropriate cell numbers in proliferating tissues, and removal of potentially dangerous cells such as autoreactive lymphocytes. A critical distinguishing feature is the absence of inflammation, as apoptotic cells are rapidly phagocytosed before they can release their contents and trigger an inflammatory response.

The causes of apoptosis span both physiologic and pathologic conditions. Physiologic apoptosis occurs during embryogenesis to sculpt organs and eliminate vestigial structures, and in hormone-dependent tissue involution such as endometrial shedding during menstruation. Pathologic apoptosis is triggered by DNA damage from radiation or cytotoxic drugs that activate the intrinsic pathway, and by viral infections where host cells undergo apoptosis to limit viral spread. Immune-mediated apoptosis occurs when cytotoxic T lymphocytes or natural killer cells induce target cell death through the extrinsic pathway or perforin-granzyme mechanisms.

The morphology of apoptosis differs markedly from necrosis and provides important diagnostic clues. Cell shrinkage rather than swelling is characteristic, with the cytoplasm becoming dense and eosinophilic. Chromatin condenses at the nuclear periphery and the nucleus fragments into discrete pieces. The cell breaks apart into membrane-bound apoptotic bodies containing cytoplasm, organelles, and nuclear fragments. These apoptotic bodies display phosphatidylserine on their outer membrane surface, serving as an "eat me" signal that promotes rapid phagocytosis by macrophages and neighboring cells.

The biochemical features of apoptosis include activation of caspases, a family of cysteine proteases that cleave substrates after aspartic acid residues. Caspase activation results in systematic dismantling of the cell through cleavage of cytoskeletal proteins, nuclear lamins, and DNA repair enzymes. Endonuclease activation produces characteristic DNA fragmentation into nucleosome-sized fragments, visible as a ladder pattern on gel electrophoresis. The externalization of phosphatidylserine from the inner to outer membrane leaflet marks apoptotic cells for phagocytic clearance before membrane integrity is lost.

<image>Panel A: Morphologic comparison of apoptosis and necrosis side by side, highlighting cell shrinkage versus swelling, chromatin condensation versus dissolution, and apoptotic body formation versus cell lysis. Panel B: Diagram showing the physiologic roles of apoptosis in embryonic development with elimination of interdigital webs and in immune system development with deletion of autoreactive lymphocytes. Panel C: Electron microscopy illustration of an apoptotic cell showing chromatin condensation, cytoplasmic condensation, and formation of membrane-bound apoptotic bodies. Panel D: Schematic of phosphatidylserine externalization and its role as an "eat me" signal for phagocyte recognition and uptake.</image>

VII. Apoptosis Pathways

The intrinsic (mitochondrial) pathway of apoptosis is activated by intracellular stresses including DNA damage, oxidative stress, and growth factor withdrawal. These stimuli alter the balance of pro-apoptotic and anti-apoptotic members of the Bcl-2 protein family, which serve as the arbiters of cell fate. When pro-apoptotic signals predominate, Bax and Bak proteins oligomerize in the mitochondrial outer membrane, forming pores that allow cytochrome c release into the cytoplasm. Cytoplasmic cytochrome c binds Apaf-1 and procaspase-9 to form the apoptosome, a molecular platform that activates caspase-9 and initiates the execution phase.

The extrinsic (death receptor) pathway is triggered by binding of death ligands to their cognate receptors on the cell surface. Death receptors including Fas and TNFR1 belong to the tumor necrosis factor receptor superfamily and contain cytoplasmic death domains essential for signal transduction. Ligand binding induces receptor trimerization and recruitment of adaptor proteins such as FADD, which contain death effector domains that recruit and activate initiator caspase-8. Active caspase-8 can directly cleave and activate executioner caspases, or it may amplify the signal through the intrinsic pathway by cleaving the BH3-only protein Bid.

The executioner caspases, principally caspase-3, carry out the demolition phase of apoptosis by cleaving numerous cellular substrates. Cleavage of cytoskeletal proteins including actin and intermediate filaments results in cell rounding and detachment. Caspase-mediated cleavage of nuclear lamins causes nuclear envelope breakdown and chromatin condensation. Inactivation of DNA repair enzymes such as PARP ensures that DNA fragmentation proceeds without repair attempts. Caspase activation of the endonuclease CAD (caspase-activated DNase) through cleavage of its inhibitor ICAD produces the characteristic internucleosomal DNA fragmentation.

Anti-apoptotic mechanisms provide crucial protection against inappropriate cell death and are often exploited by cancer cells. The Bcl-2 and Bcl-xL proteins prevent cytochrome c release by inhibiting Bax and Bak oligomerization at the mitochondrial membrane. The inhibitor of apoptosis proteins (IAPs) directly bind and inhibit caspases, preventing their enzymatic activity. FLIP (FLICE-inhibitory protein) blocks caspase-8 activation at the death-inducing signaling complex. Overexpression of anti-apoptotic proteins contributes to treatment resistance in cancer, making these molecules attractive therapeutic targets.

<image>Panel A: Detailed molecular diagram of the intrinsic apoptosis pathway showing BH3-only proteins, Bax/Bak activation, mitochondrial outer membrane permeabilization, and apoptosome assembly. Panel B: Schematic of the extrinsic pathway with death receptor trimerization, FADD recruitment, and caspase-8 activation leading to executioner caspase cleavage. Panel C: Illustration of caspase cascade showing the hierarchy from initiator caspases (8, 9) to executioner caspases (3, 6, 7) and their respective substrates. Panel D: Diagram showing anti-apoptotic proteins including Bcl-2, Bcl-xL, IAPs, and FLIP with their mechanisms of action at different points in the apoptosis pathways.</image>

VIII. Cellular Adaptations

Hypertrophy represents an increase in cell size without cell division, resulting in enlargement of the affected organ or tissue. This adaptation occurs in cells with limited or no capacity for division, such as cardiac myocytes and skeletal muscle fibers, in response to increased functional demand. Physiologic hypertrophy is seen in the hearts of trained athletes and in the gravid uterus during pregnancy, where hormonal stimulation and mechanical stretch drive cellular enlargement. Pathologic hypertrophy occurs in cardiac muscle responding to sustained pressure overload from hypertension or valvular disease, initially serving as compensation but potentially progressing to failure.

Hyperplasia is characterized by an increase in cell number through enhanced cell division and occurs in tissues containing cells capable of replication. Physiologic hyperplasia includes hormonal stimulation such as breast development at puberty and compensatory hyperplasia following partial hepatectomy. Pathologic hyperplasia results from excessive hormonal or growth factor stimulation, as seen in benign prostatic hyperplasia and endometrial hyperplasia. While hyperplasia itself is a controlled process distinct from cancer, pathologic hyperplasia may provide a fertile ground for accumulation of mutations that lead to malignancy.

Atrophy describes a decrease in cell size and number, representing shrinkage of a previously normal tissue. The mechanisms underlying atrophy include increased protein degradation via the ubiquitin-proteasome pathway and autophagy, the process by which cells digest their own components. Causes of atrophy include disuse of skeletal muscle, denervation leading to loss of trophic signals, reduced blood supply causing ischemic atrophy, inadequate nutrition, and loss of endocrine stimulation. Pathologic examples include cerebral atrophy in Alzheimer disease and muscle wasting in cachexia associated with cancer or chronic illness.

Metaplasia represents a reversible change in which one differentiated adult cell type is replaced by another differentiated cell type. This adaptation occurs through reprogramming of stem cells rather than transformation of existing mature cells, with the new cell type typically better suited to withstand an altered environment. The classic example is squamous metaplasia of respiratory epithelium in smokers, where the protective stratified squamous epithelium replaces the more vulnerable ciliated columnar epithelium. Barrett esophagus represents intestinal metaplasia of esophageal squamous epithelium in response to chronic acid reflux. While metaplasia is adaptive, it carries significance as a risk factor for dysplasia and cancer development.

<image>Panel A: Comparison of normal heart with pathologic cardiac hypertrophy showing increased wall thickness and myocyte size at the cellular level with visible sarcomere addition. Panel B: Illustration of endometrial hyperplasia showing increased gland density compared to normal proliferative endometrium. Panel C: Skeletal muscle atrophy with decreased fiber size and increased fat infiltration compared to normal muscle architecture. Panel D: Squamous metaplasia in bronchial epithelium showing replacement of ciliated columnar epithelium with stratified squamous epithelium.</image>

IX. Intracellular Accumulations

Lipid accumulations represent one of the most common forms of intracellular storage, with fatty change (steatosis) being particularly prevalent in the liver. Steatosis develops when the balance between lipid uptake, synthesis, and export is disrupted, causing triglycerides to accumulate within hepatocytes as cytoplasmic vacuoles. Alcohol is the most common cause in Western countries, impairing fatty acid oxidation and increasing lipid synthesis. Other causes include obesity, diabetes mellitus, and hepatotoxins such as carbon tetrachloride. Cholesterol accumulation manifests as foam cells in atherosclerotic plaques, where lipid-laden macrophages contribute to plaque development and complications.

Protein accumulations occur when abnormal proteins accumulate faster than they can be degraded by the proteasome system or when normal secretory proteins are trapped within cells. Hyaline droplets appear in renal tubular epithelium when excessive protein filtered at the glomerulus is reabsorbed, indicating proteinuria from glomerular disease. Russell bodies represent immunoglobulin accumulation within plasma cells, forming characteristic rounded eosinophilic inclusions. Mallory-Denk bodies in alcoholic hepatitis consist of aggregated intermediate filament proteins, particularly keratins, that have been ubiquitinated for degradation. Alpha-1-antitrypsin deficiency causes accumulation of misfolded protein within hepatocytes, leading to cirrhosis.

Glycogen accumulations occur in disorders of glucose or glycogen metabolism, where impaired utilization or excessive synthesis leads to storage. In diabetes mellitus, intracellular glycogen accumulates in hepatocytes and renal tubular epithelium despite systemic hyperglycemia, reflecting altered insulin signaling. The glycogen storage diseases represent inherited deficiencies of enzymes required for glycogen metabolism, each with characteristic patterns of organ involvement and clinical manifestations. Pompe disease (type II) affects lysosomes and causes cardiomegaly and muscle weakness, while von Gierke disease (type I) primarily affects liver and kidney.

Pigment accumulations include both exogenous substances and endogenous products of metabolism. Hemosiderin, a golden-brown iron-containing pigment, accumulates following hemorrhage or hemolysis, and in systemic iron overload (hemochromatosis). Lipofuscin, the "wear and tear" pigment, consists of indigestible lipid-protein complexes that accumulate in lysosomes of aging cells, particularly neurons and cardiac myocytes. Melanin accumulates in melanocytes and is transferred to keratinocytes, with abnormalities causing conditions ranging from vitiligo to melanoma. Carbon (anthracotic) pigment is an exogenous pigment inhaled from polluted air or cigarette smoke that accumulates in pulmonary macrophages and lymph nodes.

<image>Panel A: Liver biopsy showing macrovesicular steatosis with large clear vacuoles displacing the nucleus to the cell periphery, compared to normal hepatocytes. Panel B: Renal tubular epithelium containing hyaline droplets representing reabsorbed protein, with PAS staining highlighting the inclusions. Panel C: Histologic appearance of hemosiderin deposits in tissue with Prussian blue iron stain showing characteristic blue coloration. Panel D: Lipofuscin granules in cardiac myocytes appearing as golden-brown perinuclear granular deposits on H&E staining.</image>

X. Pathologic Calcification

Dystrophic calcification refers to the deposition of calcium salts in dead, dying, or degenerating tissue in the presence of normal serum calcium levels. The pathogenesis involves nucleation of calcium phosphate crystals on cellular debris and damaged organelles that provide binding sites for mineral deposition. Common sites include areas of necrosis such as atherosclerotic plaques, damaged cardiac valves, and the caseous centers of tuberculous granulomas. The clinical significance varies depending on location; calcification of cardiac valves can cause stenosis or regurgitation, while calcified lymph nodes and lung granulomas may be incidental radiographic findings.

Metastatic calcification occurs when calcium is deposited in normal tissues as a consequence of hypercalcemia. The elevated serum calcium disturbs the calcium-phosphate equilibrium, promoting precipitation in tissues. Common causes of hypercalcemia leading to metastatic calcification include primary hyperparathyroidism with excessive PTH secretion, osteolytic bone metastases releasing calcium, vitamin D toxicity, and chronic renal failure with secondary hyperparathyroidism. The tissues most commonly affected are those that secrete acid (such as gastric mucosa), where the local alkaline microenvironment promotes calcium deposition.

The mechanism of calcium deposition involves several factors that influence mineral solubility and precipitation. Changes in local pH affect calcium phosphate solubility, with alkaline conditions favoring precipitation. Damaged tissue provides nucleation sites where crystallization can begin, with matrix vesicles from injured cells serving as particularly effective seeds. The calcium-phosphate product, when elevated, exceeds the solubility threshold and drives mineral deposition. In progressive calcification, initial crystalline deposits serve as templates for continued mineral accretion.

The clinical significance of pathologic calcification extends across multiple organ systems. Cardiac calcification affects both valves and coronary arteries, with valvular calcification causing stenosis (particularly aortic stenosis in the elderly) and arterial calcification contributing to atherosclerotic disease. Vascular calcification includes not only atherosclerotic intimal calcification but also Monckeberg medial sclerosis, a distinct pattern affecting muscular arteries in older individuals. Calciphylaxis, a severe form of metastatic calcification in patients with renal failure, causes painful skin necrosis with very high mortality. Soft tissue calcification may also occur in connective tissue diseases and following tissue injury.

<image>Panel A: Cross-section of aortic valve showing dystrophic calcification with dense calcium deposits on the valve leaflets causing stenosis, with corresponding echocardiographic appearance. Panel B: Chest X-ray and gross specimen showing calcified tuberculous granulomas with characteristic eggshell pattern. Panel C: Histologic appearance of metastatic calcification in gastric mucosa with basophilic calcium deposits, accompanied by serum calcium pathway diagram. Panel D: Clinical photograph and histopathology of calciphylaxis showing skin necrosis with medial vascular calcification.</image>

Summary

• Cell injury causes include hypoxia, toxins, physical and chemical agents, immunologic reactions, and genetic defects
• Key mechanisms of injury involve ATP depletion, calcium influx, reactive oxygen species damage, and membrane injury
• Reversible injury features include cell swelling and fatty change with potential for recovery if the stimulus is removed
• Irreversible injury is characterized by membrane damage and nuclear changes leading to cell death
• Necrosis is pathologic cell death with inflammation, occurring as coagulative, liquefactive, caseous, or fat patterns
• Apoptosis is programmed cell death without inflammation, proceeding through intrinsic and extrinsic pathways
• Cellular adaptations include hypertrophy, hyperplasia, atrophy, and metaplasia as responses to stress
• Intracellular accumulations involve lipids, proteins, glycogen, and pigments
• Dystrophic calcification occurs in dead tissue with normal calcium levels
• Metastatic calcification occurs in normal tissue with elevated serum calcium

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown